Skip to main content

vTv Therapeutics Announces Oral Presentation at Breakthrough T1D Clinical and Research Congress 2026

New research spotlights hypoglycemia-related burdens in adults with type 1 diabetes using automated insulin delivery systems HIGH POINT, N.C., Oct. 10, 2026 (GLOBE NEWSWIRE) — vTv Therapeutics Inc. (Nasdaq: VTVT), a late-stage biopharmaceutical company advancing cadisegliatin, a novel oral investigational therapy for type 1 diabetes (T1D), today announced that Chief Medical Officer Thomas Strack, M.D., Ph.D., presented research spotlighting hypoglycemia-related burdens among adults with T1D using automated insulin delivery (AID) systems at the inaugural Breakthrough T1D Clinical & Research Congress (CRC 2026) in Philadelphia, PA. Cadisegliatin is a potential first-in-class, liver-selective glucokinase activator (GKA) being evaluated as an oral adjunctive therapy to insulin for the treatment of T1D.        “A Cumulative Population...

Continue reading

LB Pharmaceuticals Presents New Preclinical Data Supporting LB-102’s Bimodal Mechanism of Action and Highlights Ongoing Late-Stage Clinical Development Programs at the 39th ECNP Congress

NEW YORK, Oct. 10, 2026 (GLOBE NEWSWIRE) — LB Pharmaceuticals Inc (“LB Pharmaceuticals” or the “Company”) (Nasdaq: LBRX), a neuromedicines company dedicated to developing and commercializing high-impact therapies that address the multiple dimensions of underserved brain disorders, today announced the presentation of four posters at the 39th European College of Neuropsychopharmacology (ECNP) Congress, taking place in Munich, Germany from October 10-13, 2026. The posters highlight new preclinical data describing LB-102’s differentiated mechanism of action, the pivotal program of LB-102 in schizophrenia (NOVA-2 and NOVA-3), the ongoing late-stage development of LB-102 in bipolar depression (ILLUMINATE-1), and a previously reported analysis of LB-102’s impact on cognitive performance from the Phase 2 NOVA-1 trial in schizophrenia. “Our...

Continue reading

Green Thumb Opens RISE Dispensary in Cape Coral, Expanding Florida Footprint to 25 Locations

RISE Dispensaries will serve medical patients in one of Southwest Florida’s fastest-growing, waterfront communities with the opening of RISE Dispensary Cape Coral, located at 928 NE Pine Island Road. RISE Dispensary Cape Coral opens Oct. 10 and will celebrate its grand opening event on Saturday, Oct. 31 at 9:00 a.m. ET. Continuing with RISE’s new store opening tradition, a portion of profits from RISE Dispensary Cape Coral’s grand opening will benefit local nonprofit The Grateful Veteran.CHICAGO and VANCOUVER, British Columbia, Oct. 10, 2026 (GLOBE NEWSWIRE) — RISE Dispensaries, an industry-leading cannabis retail chain owned by Green Thumb Industries Inc. (“Green Thumb” or the “Company”) (CSE: GTII) (OTCQX: GTBIF), today announced the opening of RISE Dispensary Cape Coral, Florida, on October 10. Located at 928 NE Pine Island...

Continue reading

Sigenergy Unveils the Latest Energy Solutions at Malaysia’s IGEM 2026

KUALA LUMPUR, Malaysia, Oct. 10, 2026 (GLOBE NEWSWIRE) — Sigenergy is making its third appearance at the International Greentech & Eco Products Exhibition & Conference Malaysia (IGEM), showcasing its latest intelligent energy solutions and strengthening strategic partnerships across the Malaysian market.A key highlight of the event is the keynote presentation, “Sigenergy: Innovating with AI, Powering the Future Together,” which explores how AI-driven innovation is shaping the next generation of smart energy systems and supporting the transition toward a more sustainable energy future. Sigenergy also marked an important milestone in its local ecosystem through MOU exchanges with strategic partners Milieu and YT Energy, a subsidiary of Yayasan Pahang, reinforcing collaboration to accelerate the adoption of advanced energy...

Continue reading

MannKind Data at HFSA 2026 Highlights New Evidence Supporting Furoscix ReadyFlow™ for the Outpatient Management of Edema in Heart Failure (HF) and Chronic Kidney Disease (CKD)

Furoscix ReadyFlow™Furoscix ReadyFlow™Furoscix ReadyFlow™Furoscix ReadyFlow™New analyses on Furoscix ReadyFlow PK/PD performance delivered via an autoinjector demonstrated comparable urine output to IV furosemide Consistent bioavailability, diuresis and natriuresis across injection sites support flexible administration in clinical practice Cross-study analysis demonstrates comparable diuretic and natriuretic responses between Furoscix ReadyFlow and Furoscix® (furosemide) On-body Infusor, supporting a seamless transition to ReadyFlow Data presentations build on the July 2026 FDA approval and U.S. launch of Furoscix ReadyFlow, the first and only autoinjector delivering IV-equivalent diuretic therapy for heart failure- and CKD-related edema (fluid overload)WESTLAKE VILLAGE, Calif., Oct. 09,...

Continue reading

Brookfield Renewable Partners Announces New Date for Meeting on Proposed Corporate Simplification

Votes received to date have been overwhelmingly in support Meeting has been adjourned to October 29, 2026 to meet approval requirement Unitholders with questions or who require assistance voting should contact BEP’s proxy solicitation agent, Laurel Hill Advisory Group, by calling 1-877-452-7184 (toll-free within North America) or 1-416-304-0211 (outside of North America), texting “INFO” to either number, or by emailing assistance@laurelhill.com.BROOKFIELD, NEWS, Oct. 09, 2026 (GLOBE NEWSWIRE) — Brookfield Renewable Partners (“BEP”) (TSX: BEP.UN, NYSE: BEP) today announced a new date for the special meeting of unitholders of BEP (the “Unitholders’ Meeting” or the “Meeting”) in respect of the proposed corporate structure simplification (the “Simplification”). Votes received to date demonstrate overwhelming support for the Simplification,...

Continue reading

Coastal Community Bank Invests in Workforce Housing Through Koz Development’s PNW Attainable Workforce Housing Fund

Investment supports attainable housing for working individuals and families and helps leverage innovative public-private-philanthropic housing programs. EVERETT, Wash., Oct. 09, 2026 (GLOBE NEWSWIRE) — Coastal Community Bank (the “Bank”, “Coastal”, “our”) announced its participation in Koz Development’s PNW Attainable Workforce Housing Fund, a community development investment focused on expanding high-quality, environmentally responsible housing for working individuals and families across the Pacific Northwest. Koz Development’s PNW Attainable Workforce Housing Fund (“Fund”) was established to provide equity financing for attainable and workforce housing in growing communities throughout Washington and Oregon. The Fund focuses on well-located housing near employment centers, educational institutions, transportation,...

Continue reading

Brookfield Infrastructure Corporation Announces New Date for Meeting on Proposed Corporate Simplification

Votes received to date have been strongly in support Meeting has been adjourned to October 29, 2026 Shareholders with questions or who require assistance voting should contact BIPC’s proxy solicitation agent, Laurel Hill Advisory Group, by calling 1-877-452-7184 (toll-free within North America) or 1-416-304-0211 (outside of North America), texting “INFO” to either number, or by emailing assistance@laurelhill.comBROOKFIELD, NEWS, Oct. 09, 2026 (GLOBE NEWSWIRE) — Brookfield Infrastructure Corporation (“BIPC”) (TSX, NYSE: BIPC) today announced a new date for the special meeting of shareholders of BIPC (the “Shareholders’ Meeting” or the “Meeting”) in respect of the proposed corporate structure simplification (the “Simplification”). While votes received to date demonstrate support for the Simplification, the new date will allow...

Continue reading

Orca Energy Group Provides Update on Songo Songo Licence, Operations, and the Proposed Transaction

TORTOLA, British Virgin Islands, Oct. 09, 2026 (GLOBE NEWSWIRE) — Orca Energy Group Inc. (“Orca” or the “Company”) (TSX-V: ORC.A, ORC.B) provides an update regarding a proposed extension of the Songo Songo Development Licence (the “Licence”), related operational matters concerning PanAfrican Energy Tanzania Limited (“PAET”), and the Company’s previously announced proposed transaction (the “Proposed Transaction”) involving Taifa Gas Tanzania Limited and Amber Energy Investment L.L.C-FZ (the “Purchasers”). The Company also notes that, on October 5, 2026, the Fair Competition Commission of Tanzania (the “FCC”) issued a notice prohibiting the merger application relating to the Proposed Transaction. Proposed Licence Extension On October 1, 2026, the Minister of Energy of Tanzania (the “MoE”) issued a notice of intention to grant an extension...

Continue reading

NexGold Reminds Warrant Holders of Upcoming Expiry

Not for Distribution to U.S. Newswire Services or Dissemination in the United States TORONTO, Oct. 09, 2026 (GLOBE NEWSWIRE) — NexGold Mining Corp. (TSXV: NEXG; OTCQX: NXGCF) (“NexGold” or the “Company”) reminds holders of its common share purchase warrants issued pursuant to the Company’s flow-through private placement completed on November 6, 2024 (the “Warrants”) that the Warrants will expire at 5:00 p.m. (Toronto time) on Friday, November 6, 2026 (the “Expiry Date”). Each Warrant entitles the holder to acquire one common share of the Company at an exercise price of $1.05 until the Expiry Date. The original financing terms disclosed by the Company provided for a 24-month exercise period from November 6, 2024. As of October 8, 2026, 1,211,250 Warrants remain outstanding. Any Warrants not exercised in accordance with their terms...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.